Synopsis
Synopsis
0
VMF
DRUG PRODUCT COMPOSITIONS0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Anafranil
2. Chlomipramine
3. Chlorimipramine
4. Clomipramine
5. Clomipramine Maleate (1:1)
6. Clomipramine Monohydrochloride
7. Hydiphen
8. Hydrochloride, Clomipramine
9. Monohydrochloride, Clomipramine
1. 17321-77-6
2. Clomipramine Hcl
3. Anafranil
4. 3-(3-chloro-10,11-dihydro-5h-dibenzo[b,f]azepin-5-yl)-n,n-dimethylpropan-1-amine Hydrochloride
5. Chlorimipramine Hydrochloride
6. 3-chloroimipramine Hydrochloride
7. Chloroimipramine Monohydrochloride
8. Clomipramine (hydrochloride)
9. Clomipramine Monohydrochloride
10. 2lxw0l6gwj
11. Nsc-759323
12. G 34586
13. Mls000028511
14. Chebi:3755
15. G-34586
16. 3-chloro-5-(3-(dimethylamino)propyl)-10,11-dihydro-5h-dibenz(b,f)azepine Monohydrochloride
17. 5h-dibenz(b,f)azepine-5-propanamine, 3-chloro-10,11-dihydro-n,n-dimethyl-, Monohydrochloride
18. Anaphranil
19. Smr000058295
20. Anafranil (tn)
21. 3-(2-chloro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)-n,n-dimethylpropan-1-amine;hydrochloride
22. (3-{5-chloro-2-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl}propyl)dimethylamine Hydrochloride
23. 3-(3-chloro-10,11-dihydro-5h-dibenzo[b,f]azepin-5-yl)-n,n-dimethylpropan-1-aminium Chloride
24. 5h-dibenz[b,f]azepine-5-propanamine, 3-chloro-10,11-dihydro-n,n-dimethyl-, Hydrochloride (1:1)
25. Anafranil Hydrochloride
26. Sr-01000003088
27. Einecs 241-344-3
28. Unii-2lxw0l6gwj
29. Cas-17321-77-6
30. Clomipramine, Hcl
31. Prestwick_72
32. Mfcd00069234
33. Vr-776
34. Cpd000058295
35. I615
36. Opera_id_368
37. Clomipramine Hydrochloride [usan:usp:jan]
38. Dsstox_cid_22633
39. Dsstox_rid_80064
40. Dsstox_gsid_42633
41. Schembl41747
42. Mls001074205
43. Mls002222159
44. Mls002548879
45. Spectrum2300061
46. Regid_for_cid_68539
47. Chembl1200710
48. Clomipramine-[d6] Hydrochloride
49. Dtxsid3042633
50. Clomipramine Hydrochloride- Bio-x
51. Hms1568f20
52. Pharmakon1600-02300061
53. Amy40405
54. Bcp28468
55. Hy-b0457
56. Tox21_301819
57. Tox21_500307
58. Ccg-39492
59. Nsc759323
60. S2541
61. Anafranil Hydrochloride; Chloripramine
62. Akos015895084
63. Clomipramine Hydrochloride (anafranil)
64. Ac-8082
65. Clomipramine Hydrochloride (jp17/usp)
66. Clomipramine Hydrochloride [mi]
67. Ks-1044
68. Lp00307
69. Nc00678
70. Nsc 759323
71. (non-labelled)clomipramine-13c-d3 Hcl
72. Clomipramine Hydrochloride [jan]
73. Clomipramine Hydrochloride [usan]
74. Ncgc00093756-01
75. Ncgc00093756-02
76. Ncgc00093756-03
77. Ncgc00093756-04
78. Ncgc00178275-01
79. Ncgc00178275-02
80. Ncgc00255897-01
81. Ncgc00260992-01
82. 5h-dibenz(b,f)azepine, 10,11-dihydro-3-chloro-5-(3-(dimethylamino)propyl)-, Monohydrochloride
83. Bc164325
84. Clomipramine Hydrochloride [mart.]
85. Clomipramine Hydrochloride [vandf]
86. Clomipramine Hydrochloride [usp-rs]
87. Clomipramine Hydrochloride [who-dd]
88. Eu-0100307
89. Ft-0623989
90. Sw196384-4
91. C 7291
92. Clomipramine Hydrochloride [green Book]
93. Clomipramine Hydrochloride [orange Book]
94. D00811
95. Mls-0090819.0001
96. Clomipramine Hydrochloride [ep Monograph]
97. 321c776
98. Clomipramine Hydrochloride [usp Monograph]
99. Clomipramine Hydrochloride, >=98% (hplc), Powder
100. Sr-01000003088-2
101. Sr-01000003088-4
102. Sr-01000003088-5
103. Sr-01000003088-9
104. Q27106187
105. Clomipramine Hydrochloride 1.0 Mg/ml In Methanol (as Free Base)
106. Clomipramine Hydrochloride, British Pharmacopoeia (bp) Reference Standard
107. 3-chloro-10,11-dihydro-n,n-dimethyl-5h-dibenz(z)[b,f]azepine-5-propanamine Hydrochloride
108. Clomipramine Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
109. Clomipramine Hydrochloride, United States Pharmacopeia (usp) Reference Standard
110. 3-(3-chloro-10,11-dihydro-5h-dibenzo[b,f]azepin-5-yl)-n,n-dimethylpropan-1-amine Hcl
111. Clomipramine Hydrochloride Solution, 1.0 Mg/ml In Methanol (as Free Base), Ampule Of 1 Ml, Certified Reference Material
112. Clomipramine Hydrochloride, For Microbiological Assay, European Pharmacopoeia (ep) Reference Standard
| Molecular Weight | 351.3 g/mol |
|---|---|
| Molecular Formula | C19H24Cl2N2 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 4 |
| Exact Mass | 350.1316542 g/mol |
| Monoisotopic Mass | 350.1316542 g/mol |
| Topological Polar Surface Area | 6.5 Ų |
| Heavy Atom Count | 23 |
| Formal Charge | 0 |
| Complexity | 346 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
| 1 of 4 | |
|---|---|
| Drug Name | Anafranil |
| PubMed Health | Clomipramine (By mouth) |
| Drug Classes | Antidepressant, Central Nervous System Agent |
| Drug Label | Anafranil (clomipramine hydrochloride) Capsules USP is an antiobsessional drug that belongs to the class (dibenzazepine) of pharmacologic agents known as tricyclic antidepressants. Anafranil is available as capsules of 25, 50, and 75 mg for oral a... |
| Active Ingredient | Clomipramine hydrochloride |
| Dosage Form | Capsule |
| Route | Oral |
| Strength | 75mg; 25mg; 50mg |
| Market Status | Prescription |
| Company | Mallinckrodt |
| 2 of 4 | |
|---|---|
| Drug Name | Clomipramine hydrochloride |
| Drug Label | Clomipramine hydrochloride capsules USP are an antiobsessional drug that belongs to the class (dibenzazepine) of pharmacologic agents known as tricyclic antidepressants. Clomipramine hydrochloride is available as capsules of 25, 50 and 75 mg for oral... |
| Active Ingredient | Clomipramine hydrochloride |
| Dosage Form | Capsule |
| Route | Oral |
| Strength | 75mg; 25mg; 50mg |
| Market Status | Prescription |
| Company | Teva; Taro; Sandoz; Mylan |
| 3 of 4 | |
|---|---|
| Drug Name | Anafranil |
| PubMed Health | Clomipramine (By mouth) |
| Drug Classes | Antidepressant, Central Nervous System Agent |
| Drug Label | Anafranil (clomipramine hydrochloride) Capsules USP is an antiobsessional drug that belongs to the class (dibenzazepine) of pharmacologic agents known as tricyclic antidepressants. Anafranil is available as capsules of 25, 50, and 75 mg for oral a... |
| Active Ingredient | Clomipramine hydrochloride |
| Dosage Form | Capsule |
| Route | Oral |
| Strength | 75mg; 25mg; 50mg |
| Market Status | Prescription |
| Company | Mallinckrodt |
| 4 of 4 | |
|---|---|
| Drug Name | Clomipramine hydrochloride |
| Drug Label | Clomipramine hydrochloride capsules USP are an antiobsessional drug that belongs to the class (dibenzazepine) of pharmacologic agents known as tricyclic antidepressants. Clomipramine hydrochloride is available as capsules of 25, 50 and 75 mg for oral... |
| Active Ingredient | Clomipramine hydrochloride |
| Dosage Form | Capsule |
| Route | Oral |
| Strength | 75mg; 25mg; 50mg |
| Market Status | Prescription |
| Company | Teva; Taro; Sandoz; Mylan |
As an aid in the treatment of separation related disorders in dogs manifested by destruction and inappropriate elimination (defecation and urination) and only in combination with behavioural modification techniques.
Antidepressive Agents, Tricyclic
Substances that contain a fused three-ring moiety and are used in the treatment of depression. These drugs block the uptake of norepinephrine and serotonin into axon terminals and may block some subtypes of serotonin, adrenergic, and histamine receptors. However, the mechanism of their antidepressant effects is not clear because the therapeutic effects usually take weeks to develop and may reflect compensatory changes in the central nervous system. (See all compounds classified as Antidepressive Agents, Tricyclic.)
Selective Serotonin Reuptake Inhibitors
Compounds that specifically inhibit the reuptake of serotonin in the brain. (See all compounds classified as Selective Serotonin Reuptake Inhibitors.)
QN06AA04
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Australia
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - CAPSULE;ORAL - 25MG
USFDA APPLICATION NUMBER - 19906
DOSAGE - CAPSULE;ORAL - 50MG
USFDA APPLICATION NUMBER - 19906
DOSAGE - CAPSULE;ORAL - 75MG
USFDA APPLICATION NUMBER - 19906
Related Excipient Companies
SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Faran Shimi Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Boai NKY Pharmaceuticals Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ACG Worldwide
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DFE Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ingredion Pharma Solutions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Lonza Capsugel
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Novo Excipients
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharmatrans-Sanaq
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Prachin Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qualicaps
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seppic
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Sigachi Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Applications
Fillers, Diluents & Binders
Granulation
Direct Compression
Lubricants & Glidants
Coating Systems & Additives
Thickeners and Stabilizers
Empty Capsules
Solubilizers
Taste Masking
Co-Processed Excipients
Film Formers & Plasticizers
Controlled & Modified Release
Emulsifying Agents
Disintegrants & Superdisintegrants
Parenteral
Topical
Coloring Agents
Chewable & Orodispersible Aids
API Stability Enhancers
Surfactant & Foaming Agents
Digital Content
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
33
PharmaCompass offers a list of Clomipramine Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Clomipramine Hydrochloride manufacturer or Clomipramine Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Clomipramine Hydrochloride manufacturer or Clomipramine Hydrochloride supplier.
PharmaCompass also assists you with knowing the Clomipramine Hydrochloride API Price utilized in the formulation of products. Clomipramine Hydrochloride API Price is not always fixed or binding as the Clomipramine Hydrochloride Price is obtained through a variety of data sources. The Clomipramine Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Clomipramine HCl manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Clomipramine HCl, including repackagers and relabelers. The FDA regulates Clomipramine HCl manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Clomipramine HCl API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Clomipramine HCl manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Clomipramine HCl supplier is an individual or a company that provides Clomipramine HCl active pharmaceutical ingredient (API) or Clomipramine HCl finished formulations upon request. The Clomipramine HCl suppliers may include Clomipramine HCl API manufacturers, exporters, distributors and traders.
click here to find a list of Clomipramine HCl suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Clomipramine HCl DMF (Drug Master File) is a document detailing the whole manufacturing process of Clomipramine HCl active pharmaceutical ingredient (API) in detail. Different forms of Clomipramine HCl DMFs exist exist since differing nations have different regulations, such as Clomipramine HCl USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Clomipramine HCl DMF submitted to regulatory agencies in the US is known as a USDMF. Clomipramine HCl USDMF includes data on Clomipramine HCl's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Clomipramine HCl USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Clomipramine HCl suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Clomipramine HCl Drug Master File in Japan (Clomipramine HCl JDMF) empowers Clomipramine HCl API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Clomipramine HCl JDMF during the approval evaluation for pharmaceutical products. At the time of Clomipramine HCl JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Clomipramine HCl suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Clomipramine HCl Drug Master File in Korea (Clomipramine HCl KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Clomipramine HCl. The MFDS reviews the Clomipramine HCl KDMF as part of the drug registration process and uses the information provided in the Clomipramine HCl KDMF to evaluate the safety and efficacy of the drug.
After submitting a Clomipramine HCl KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Clomipramine HCl API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Clomipramine HCl suppliers with KDMF on PharmaCompass.
A Clomipramine HCl CEP of the European Pharmacopoeia monograph is often referred to as a Clomipramine HCl Certificate of Suitability (COS). The purpose of a Clomipramine HCl CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Clomipramine HCl EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Clomipramine HCl to their clients by showing that a Clomipramine HCl CEP has been issued for it. The manufacturer submits a Clomipramine HCl CEP (COS) as part of the market authorization procedure, and it takes on the role of a Clomipramine HCl CEP holder for the record. Additionally, the data presented in the Clomipramine HCl CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Clomipramine HCl DMF.
A Clomipramine HCl CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Clomipramine HCl CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Clomipramine HCl suppliers with CEP (COS) on PharmaCompass.
A Clomipramine HCl written confirmation (Clomipramine HCl WC) is an official document issued by a regulatory agency to a Clomipramine HCl manufacturer, verifying that the manufacturing facility of a Clomipramine HCl active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Clomipramine HCl APIs or Clomipramine HCl finished pharmaceutical products to another nation, regulatory agencies frequently require a Clomipramine HCl WC (written confirmation) as part of the regulatory process.
click here to find a list of Clomipramine HCl suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Clomipramine HCl as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Clomipramine HCl API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Clomipramine HCl as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Clomipramine HCl and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Clomipramine HCl NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Clomipramine HCl suppliers with NDC on PharmaCompass.
Clomipramine HCl Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Clomipramine HCl GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Clomipramine HCl GMP manufacturer or Clomipramine HCl GMP API supplier for your needs.
A Clomipramine HCl CoA (Certificate of Analysis) is a formal document that attests to Clomipramine HCl's compliance with Clomipramine HCl specifications and serves as a tool for batch-level quality control.
Clomipramine HCl CoA mostly includes findings from lab analyses of a specific batch. For each Clomipramine HCl CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Clomipramine HCl may be tested according to a variety of international standards, such as European Pharmacopoeia (Clomipramine HCl EP), Clomipramine HCl JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Clomipramine HCl USP).
